Publish Date: 2nd August 2016
Published By: TestingQ.com
Company Name: PASS Technologies
Follow @TestingQ
Published By: TestingQ.com
Company Name: PASS Technologies
Location: Bangalore
- Excellent Manual Testing Skills & Experience
- Excellent written and verbal communication skills in English
- Possesses excellent problem solving skills, & strong attention to detail
- Quality oriented &, committed
- Willing to work with startups
- Good to have - knowledge on Test Automation tool
Date & Time: 3rd August 2016 from 10AM to 5PM
Venue: Vaishnavi Badri Towers,#48,5th Main,JayamahalExtension,BANGALORE,Karnataka,India 560046
Contact: Manjunath, 91-80-65555908
Venue: Vaishnavi Badri Towers,#48,5th Main,JayamahalExtension,BANGALORE,Karnataka,India 560046
Contact: Manjunath, 91-80-65555908
About Company:
PASS Technologies, founded in 1989, international headquarter of the PASS Group (www.pass.ch), is a leading provider of Independent Verification & Validation (V&V) and Quality Assurance (QA) Services. PASS Group has offices in Switzerland, Germany, U.S. , Eastern Europe and India, serving different industries and domains including Healthcare & Life Science, Electronics & Equipment, Banking & Financial Services, Retail, Energy, Telecommunications, Transportation & Logistics.
Through its specialized Centers of Excellence for independent V&V Services in Healthcare and Life Sciences, PASS Group supports software and system vendors of medical devices, healthcare and life science IT solutions with a complete portfolio of V&V services supporting conformity with European and US regulations such as 21 CFR 820 and 21 CFR part 11, Medical Device Directive 93/42/EEC and In-Vitro Diagnostics Directive 98/79CE.
Through its specialized Centers of Excellence for independent V&V Services in Healthcare and Life Sciences, PASS Group supports software and system vendors of medical devices, healthcare and life science IT solutions with a complete portfolio of V&V services supporting conformity with European and US regulations such as 21 CFR 820 and 21 CFR part 11, Medical Device Directive 93/42/EEC and In-Vitro Diagnostics Directive 98/79CE.
